Literature DB >> 25399331

Fat and fiber: how the controlled attenuation parameter complements noninvasive assessment of liver fibrosis.

Grace Lai-Hung Wong1, Vincent Wai-Sun Wong.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25399331     DOI： 10.1007/s10620-014-3429-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  15 in total

1.  Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(®): validation in chronic hepatitis C.

Authors:  M Sasso; I Tengher-Barna; M Ziol; V Miette; C Fournier; L Sandrin; R Poupon; A-C Cardoso; P Marcellin; C Douvin; V de Ledinghen; J-C Trinchet; M Beaugrand
Journal:  J Viral Hepat       Date:  2011-10-13       Impact factor: 3.728

2.  Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.

Authors:  Magali Sasso; Michel Beaugrand; Victor de Ledinghen; Catherine Douvin; Patrick Marcellin; Raoul Poupon; Laurent Sandrin; Véronique Miette
Journal:  Ultrasound Med Biol       Date:  2010-09-27       Impact factor: 2.998

3.  Normal controlled attenuation parameter values: a prospective study of healthy subjects undergoing health checkups and liver donors in Korea.

Authors:  Young Eun Chon; Kyu Sik Jung; Kwang Joon Kim; Dong Jin Joo; Beom Kyung Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Kwang-Hyub Han; Seung Up Kim
Journal:  Dig Dis Sci       Date:  2014-08-14       Impact factor: 3.199

4.  Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B--a prospective cohort study with paired transient elastography examinations.

Authors:  G L-H Wong; H L-Y Chan; Z Yu; A W-H Chan; P C-L Choi; A M-L Chim; H-Y Chan; C-H Tse; V W-S Wong
Journal:  Aliment Pharmacol Ther       Date:  2014-02-20       Impact factor: 8.171

5.  Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.

Authors:  Vincent Wai-Sun Wong; Winnie Chiu-Wing Chu; Grace Lai-Hung Wong; Ruth Suk-Mei Chan; Angel Mei-Ling Chim; Arlinking Ong; David Ka-Wai Yeung; Karen Kar-Lum Yiu; Shirley Ho-Ting Chu; Jean Woo; Francis Ka-Leung Chan; Henry Lik-Yuen Chan
Journal:  Gut       Date:  2011-08-16       Impact factor: 23.059

6.  Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.

Authors:  Victor de Lédinghen; Julien Vergniol; Juliette Foucher; Wassil Merrouche; Brigitte le Bail
Journal:  Liver Int       Date:  2012-07       Impact factor: 5.828

7.  Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B.

Authors:  H L-Y Chan; G L-H Wong; P C-L Choi; A W-H Chan; A M-L Chim; K K-L Yiu; F K-L Chan; J J-Y Sung; V W-S Wong
Journal:  J Viral Hepat       Date:  2008-07-28       Impact factor: 3.728

8.  Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B.

Authors:  Grace L-H Wong; Vincent W-S Wong; Paul C-L Choi; Anthony W-H Chan; Angel M-L Chim; Karen K-L Yiu; Francis K-L Chan; Joseph J-Y Sung; Henry L-Y Chan
Journal:  J Gastroenterol Hepatol       Date:  2009-04-23       Impact factor: 4.029

9.  Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B.

Authors:  G L-H Wong; V W-S Wong; P C-L Choi; A W-H Chan; A M-L Chim; K K-L Yiu; H-Y Chan; F K-L Chan; J J-Y Sung; H L-Y Chan
Journal:  Gut       Date:  2008-10-02       Impact factor: 23.059

10.  Controlled attenuation parameter for noninvasive assessment of hepatic steatosis using Fibroscan®: validation in chronic hepatitis B.

Authors:  Yu-Qiang Mi; Qi-Yu Shi; Liang Xu; Rui-Fang Shi; Yong-Gang Liu; Ping Li; Feng Shen; Wei Lu; Jian-Gao Fan
Journal:  Dig Dis Sci       Date:  2014-09-07       Impact factor: 3.199
View more
  6 in total

1.  Population-specific cut-off points of fatty liver index: a study based on the National Health and Nutrition Examination Survey data.

Authors:  Juan Wu; Shen Tian; Hao Li; Zhou Xu; Shu Li; Yu-Ling Chen; Xin-Yu Liang; Jun Xiao; Jing-Yu Song; Rui-Ling She; Chen-Yu Ma; Jun-Han Feng; Zhao-Xing Li; Zhi-Yu Jiang; Zi-Wei Zhang; Kai-Nan Wu; Ling-Quan Kong
Journal:  BMC Gastroenterol       Date:  2022-05-27       Impact factor: 2.847

2.  Prognostic Significance of Controlled Attenuation Parameter in Patients With Compensated Advanced Chronic Liver Disease.

Authors:  Cristina Margini; Giuseppe Murgia; Guido Stirnimann; Andrea De Gottardi; Nasser Semmo; Stefania Casu; Jaime Bosch; Jean-François Dufour; Annalisa Berzigotti
Journal:  Hepatol Commun       Date:  2018-07-24

3.  Novel screening model of obstructive sleep apnea for snorers with suspected NAFLD undergoing liver sonography.

Authors:  Yang-Bor Lu; Yu-Chieh Weng; Yung-Ning Huang; Hsiung-Ying Huang; Pei-Ting Cheng; Hui-Shan Hsieh; Ming-Shao Tsai
Journal:  BMC Pulm Med       Date:  2021-11-26       Impact factor: 3.317

Review 4.  Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss.

Authors:  Sjaak Pouwels; Nasser Sakran; Yitka Graham; Angela Leal; Tadeja Pintar; Wah Yang; Radwan Kassir; Rishi Singhal; Kamal Mahawar; Dharmanand Ramnarain
Journal:  BMC Endocr Disord       Date:  2022-03-14       Impact factor: 2.763

5.  Eradication of hepatitis C virus is associated with the attenuation of steatosis as evaluated using a controlled attenuation parameter.

Authors:  Kohei Shimizu; Yoko Soroida; Masaya Sato; Hiromi Hikita; Tamaki Kobayashi; Momoe Endo; Mamiko Sato; Hiroaki Gotoh; Tomomi Iwai; Ryosuke Tateishi; Kazuhiko Koike; Yutaka Yatomi; Hitoshi Ikeda
Journal:  Sci Rep       Date:  2018-05-18       Impact factor: 4.379

6.  Higher cut-off values of non-invasive methods might be needed to detect moderate-to-severe steatosis in morbid obese patients: a pilot study.

Authors:  Daniella Braz Parente; Hugo Perazzo; Fernando Fernandes Paiva; Carlos Frederico Ferreira Campos; Carlos José Saboya; Silvia Elaine Pereira; Felipe d'Almeida E Silva; Rosana Souza Rodrigues; Renata de Mello Perez
Journal:  Sci Rep       Date:  2020-09-14       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.